Compare Humana Inc (HUM) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs J B Hunt Transport Services Inc — how do they compare? Humana Inc trades at $437.41 (market cap $47.61B), while J B Hunt Transport Services Inc trades at $230 (market cap $20.91B). The key difference: Humana Inc is far larger — about 2.3× J B Hunt Transport Services Inc's market cap, and Humana Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and J B Hunt Transport Services Inc for 45 Days on average.
| HUM | JBHT | |
|---|---|---|
Market Cap | $47.61B | $20.91B |
Volume | 1,827,332 | 684,242 |
Sector | Health | Industrials |
52-Week High | $409.85 | $298.41 |
52-Week Low | $163.67 | $137.09 |
Typical Hold Time | 53 Days | 45 Days |
Enterprise Value | $54.97B | $22.05B |
Dividend Yield | 0.89% | 0.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
JBHT trades at $228.42, up 1.1% with bearish technical signals but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending. Revenue stabilized at $12B in 2025 after previous declines, while profitability improved with 5.31% net margin. Analyst consensus remains strongly bullish with $287.53 price target despite ongoing securities investigations creating headline risk.
The stock presents a divergence between bearish technical indicators and positive fundamental trajectory. Upside potential exists from earnings momentum and industry tailwinds, but risks include legal investigations and cost pressures. Wall Street's 58.7% buy rating suggests confidence in long-term value despite near-term volatility from legal overhangs and fuel cost challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
